𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ovarian serous borderline tumors: the citadel defended

✍ Scribed by Robert J. Kurman; Jeffrey D. Seidman

Book ID
117252610
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
269 KB
Volume
31
Category
Article
ISSN
1532-8392

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ovarian serous borderline tumors with in
Ovarian serous borderline tumors with invasive peritoneal implants
✍ David M. Gershenson; Elvio G. Silva; Lawrence Levy; Thomas W. Burke; Judith K. W πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 324 KB πŸ‘ 2 views

multivariate regression analyses also were performed. University of Texas M. D. Anderson Cancer Cen-RESULTS. Median follow-up time was 111 months. Four of 7 evaluable patients ter, Houston, Texas. who had second-look surgery (57%) had a response to chemotherapy. Twelve of

Treatment of micropapillary serous ovari
Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors)
✍ Jeffrey D. Seidman; Robert J. Kurman πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 32 KB πŸ‘ 1 views

Ovarian serous borderline tumors recently were categorized into benign and malignant types. A subset of these tumors, termed β€œmicropapillary serous carcinoma (MPSC),” is reported to behave in a manner similar to low‐grade carcinoma. In this issue of __Cancer__, Bristow et al. report their experience